<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35279757</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>20</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1459</ISSN><JournalIssue CitedMedium="Internet"><Volume>269</Volume><Issue>8</Issue><PubDate><Year>2022</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of neurology</Title><ISOAbbreviation>J Neurol</ISOAbbreviation></Journal><ArticleTitle>Schizotypal traits across the amyotrophic lateral sclerosis-frontotemporal dementia spectrum: pathomechanistic insights.</ArticleTitle><Pagination><StartPage>4241</StartPage><EndPage>4252</EndPage><MedlinePgn>4241-4252</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00415-022-11049-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Psychiatric presentations similar to that observed in primary psychiatric disorders are well described across the amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD) spectrum. Despite this, schizotypal personality traits associated with increased risks of clinical psychosis development and poor psychosocial outcomes have never been examined. The current study aimed to provide the first exploration of schizotypal traits and its neural underpinnings in the ALS-FTD spectrum to gain insights into a broader spectrum of psychiatric overlap with psychiatric disorders.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Schizotypal traits were assessed using the targeted Schizotypal Personality Questionnaire in 99 participants (35 behavioural variant FTD, 10 ALS-FTD and 37 ALS patients, and 17 age-, sex- and education-matched healthy controls). Voxel-based morphometry analysis of whole-brain grey matter volume was conducted.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Relative to controls, pervasive schizotypal personality traits across positive and negative schizotypy and disorganised thought disorders were identified in behavioural variant FTD, ALS (with the exception of negative schizotypy) and ALS-FTDALS-FTD patients (all p&#x2009;&lt;&#x2009;.013), suggesting the presence of a wide spectrum of subclinical schizotypal symptoms beyond classic psychotic symptoms. Atrophy in frontal, anterior cingulate and insular cortices, and caudate and thalamus was involved in positive schizotypy, while integrity of the cerebellum was associated with disorganised thought disorder traits.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The frontal-striatal-limbic regions underpinning manifestation of schizotypy in the ALS-FTDALS-FTD spectrum are similar to that established in previous schizophrenia research. This finding expands the concept of a psychiatric overlap in ALS-FTD and schizophrenia, and suggests potentially common underlying mechanisms involving disruptions to frontal-striatal-limbic networks, warranting a transdiagnostic approach for future investigations.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tse</LastName><ForeName>Nga Yan</ForeName><Initials>NY</Initials><AffiliationInfo><Affiliation>The Brain and Mind Centre, University of Sydney; and Royal Prince Alfred Hospital, 94 Mallet Street, Camperdown, Sydney, NSW, 2050, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tu</LastName><ForeName>Sicong</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>The Brain and Mind Centre, University of Sydney; and Royal Prince Alfred Hospital, 94 Mallet Street, Camperdown, Sydney, NSW, 2050, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of Psychology and Brain and Mind Centre, The University of Sydney, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caga</LastName><ForeName>Jashelle</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Brain and Mind Centre, University of Sydney; and Royal Prince Alfred Hospital, 94 Mallet Street, Camperdown, Sydney, NSW, 2050, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dobson-Stone</LastName><ForeName>Carol</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>The Brain and Mind Centre, University of Sydney; and Royal Prince Alfred Hospital, 94 Mallet Street, Camperdown, Sydney, NSW, 2050, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwok</LastName><ForeName>John B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>The Brain and Mind Centre, University of Sydney; and Royal Prince Alfred Hospital, 94 Mallet Street, Camperdown, Sydney, NSW, 2050, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halliday</LastName><ForeName>Glenda M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>The Brain and Mind Centre, University of Sydney; and Royal Prince Alfred Hospital, 94 Mallet Street, Camperdown, Sydney, NSW, 2050, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Research Australia, Randwick, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Rebekah M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>The Brain and Mind Centre, University of Sydney; and Royal Prince Alfred Hospital, 94 Mallet Street, Camperdown, Sydney, NSW, 2050, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Memory and Cognition Clinic, Department of Clinical Neurosciences, Royal Prince Alfred Hospital, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hodges</LastName><ForeName>John R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>The Brain and Mind Centre, University of Sydney; and Royal Prince Alfred Hospital, 94 Mallet Street, Camperdown, Sydney, NSW, 2050, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piguet</LastName><ForeName>Olivier</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>School of Psychology and Brain and Mind Centre, The University of Sydney, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiernan</LastName><ForeName>Matthew C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>The Brain and Mind Centre, University of Sydney; and Royal Prince Alfred Hospital, 94 Mallet Street, Camperdown, Sydney, NSW, 2050, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devenney</LastName><ForeName>Emma M</ForeName><Initials>EM</Initials><Identifier Source="ORCID">0000-0001-6140-0452</Identifier><AffiliationInfo><Affiliation>The Brain and Mind Centre, University of Sydney; and Royal Prince Alfred Hospital, 94 Mallet Street, Camperdown, Sydney, NSW, 2050, Australia. Emma.devenney@sydney.edu.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>1037746</GrantID><Agency>National Health and Medical Research Council</Agency><Country/></Grant><Grant><GrantID>1132524</GrantID><Agency>National Health and Medical Research Council</Agency><Country/></Grant><Grant><GrantID>1095127</GrantID><Agency>National Health and Medical Research Council</Agency><Country/></Grant><Grant><GrantID>APP1121859</GrantID><Agency>National Health and Medical Research Council</Agency><Country/></Grant><Grant><GrantID>Post-doctoral fellowship</GrantID><Agency>National Health and Medical Research Council</Agency><Country/></Grant><Grant><GrantID>1176607</GrantID><Agency>National Health and Medical Research Council</Agency><Country/></Grant><Grant><GrantID>APP1103258</GrantID><Agency>National Health and Medical Research Council</Agency><Country/></Grant><Grant><GrantID>CE110001021</GrantID><Agency>Centre of Excellence in Cognition and its Disorders, Australian Research Council</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Neurol</MedlineTA><NlmUniqueID>0423161</NlmUniqueID><ISSNLinking>0340-5354</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C566288">Frontotemporal Dementia With Motor Neuron Disease</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001284" MajorTopicYN="N">Atrophy</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066128" MajorTopicYN="N">Gray Matter</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Frontotemporal dementia</Keyword><Keyword MajorTopicYN="N">Motor neuron disease</Keyword><Keyword MajorTopicYN="N">Neuropsychiatry</Keyword><Keyword MajorTopicYN="N">Schizotypy</Keyword></KeywordList><CoiStatement>The authors report no conflict interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>13</Day><Hour>20</Hour><Minute>32</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35279757</ArticleId><ArticleId IdType="pmc">PMC9294025</ArticleId><ArticleId IdType="doi">10.1007/s00415-022-11049-3</ArticleId><ArticleId IdType="pii">10.1007/s00415-022-11049-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Devenney E, Vucic S, Hodges JR, Kiernan MC. Motor neuron disease-frontotemporal dementia: A clinical continuum. Expert Rev Neurother. 2015;15(5):509&#x2013;522. doi: 10.1586/14737175.2015.1034108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14737175.2015.1034108</ArticleId><ArticleId IdType="pubmed">25865485</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrell JR, et al. The frontotemporal dementia-motor neuron disease continuum. Lancet. 2016;388(10047):919&#x2013;931. doi: 10.1016/S0140-6736(16)00737-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)00737-6</ArticleId><ArticleId IdType="pubmed">26987909</ArticleId></ArticleIdList></Reference><Reference><Citation>Scarioni M, et al. Frontotemporal dementia: correlations between psychiatric symptoms and pathology. Ann Neurol. 2020;87(6):950&#x2013;961. doi: 10.1002/ana.25739.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25739</ArticleId><ArticleId IdType="pmc">PMC7318614</ArticleId><ArticleId IdType="pubmed">32281118</ArticleId></ArticleIdList></Reference><Reference><Citation>Shinagawa S, et al. Clinicopathological study of patients with C9ORF72-associated frontotemporal dementia presenting with delusions. J Geriatr Psychiatry Neurol. 2015;28(2):99&#x2013;107. doi: 10.1177/0891988714554710.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0891988714554710</ArticleId><ArticleId IdType="pmc">PMC4408221</ArticleId><ArticleId IdType="pubmed">25342578</ArticleId></ArticleIdList></Reference><Reference><Citation>Zucchi E, Ticozzi N, Mandrioli J. Psychiatric symptoms in amyotrophic lateral sclerosis: beyond a motor neuron disorder. Front Neurosci. 2019;13(March):1&#x2013;11. doi: 10.3389/fnins.2019.00175.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00175</ArticleId><ArticleId IdType="pmc">PMC6421303</ArticleId><ArticleId IdType="pubmed">30914912</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne S, et al. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: A population-based cohort study. Lancet Neurol. 2012;11(3):232&#x2013;240. doi: 10.1016/S1474-4422(12)70014-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(12)70014-5</ArticleId><ArticleId IdType="pmc">PMC3315021</ArticleId><ArticleId IdType="pubmed">22305801</ArticleId></ArticleIdList></Reference><Reference><Citation>McLaughlin RL, et al. Genetic correlation between amyotrophic lateral sclerosis and schizophrenia. Nat Commun. 2017;8:1&#x2013;12. doi: 10.1038/ncomms14774.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms14774</ArticleId><ArticleId IdType="pmc">PMC5364411</ArticleId><ArticleId IdType="pubmed">28322246</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall D, Finger EC. Psychotic Symptoms in Frontotemporal Dementia. Curr Neurol Neurosci Rep. 2015 doi: 10.1007/s11910-015-0567-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-015-0567-8</ArticleId><ArticleId IdType="pubmed">26008815</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverman HE, Goldman JS, Huey ED. Links between the C9orf72 repeat expansion and psychiatric symptoms. Curr Neurol Neurosci Rep. 2019 doi: 10.1007/s11910-019-1017-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-019-1017-9</ArticleId><ArticleId IdType="pubmed">31773397</ArticleId></ArticleIdList></Reference><Reference><Citation>Devenney E, et al. Frontotemporal dementia associated with the C9ORF72 mutation: a unique clinical profile. JAMA Neurol. 2014;71(3):331&#x2013;339. doi: 10.1001/jamaneurol.2013.6002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2013.6002</ArticleId><ArticleId IdType="pubmed">24445580</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohrer JD, et al. C9orf72 expansions in frontotemporal dementia and amyotrophic lateral sclerosis. Lancet Neurol. 2015;14(3):291&#x2013;301. doi: 10.1016/S1474-4422(14)70233-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70233-9</ArticleId><ArticleId IdType="pubmed">25638642</ArticleId></ArticleIdList></Reference><Reference><Citation>Gossink FT, et al. Psychosis in behavioral variant frontotemporal dementia. Neuropsychiatr Dis Treat. 2017;13:1099&#x2013;1106. doi: 10.2147/NDT.S127863.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/NDT.S127863</ArticleId><ArticleId IdType="pmc">PMC5402723</ArticleId><ArticleId IdType="pubmed">28458550</ArticleId></ArticleIdList></Reference><Reference><Citation>Devenney EM, Ahmed RM, Halliday G, Piguet O, Kiernan MC, Hodges JR. Psychiatric disorders in C9orf72 kindreds study of 1,414 family members. Neurology. 2018;91(16):E1498&#x2013;E1507. doi: 10.1212/WNL.0000000000006344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000006344</ArticleId><ArticleId IdType="pubmed">30258023</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter EE, Fernandez F, Snelling M, Barkus E. Genetic consideration of schizotypal traits: A review. Front Psychol. 2016 doi: 10.3389/fpsyg.2016.01769.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2016.01769</ArticleId><ArticleId IdType="pmc">PMC5108787</ArticleId><ArticleId IdType="pubmed">27895608</ArticleId></ArticleIdList></Reference><Reference><Citation>Debban&#xe9; M, Eliez S, Badoud D, Conus P, Fl&#xfc;ckiger R, Schultze-Lutter F. Developing psychosis and its risk states through the lens of schizotypy. Schizophr Bull. 2015;41(2):S396&#x2013;S407. doi: 10.1093/schbul/sbu176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/schbul/sbu176</ArticleId><ArticleId IdType="pmc">PMC4373628</ArticleId><ArticleId IdType="pubmed">25548386</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwapil TR, Gross GM, Silvia PJ, Barrantes-Vidal N. Prediction of psychopathology and functional impairment by positive and negative schizotypy in the chapmans&#x2019; ten-year longitudinal study. J Abnorm Psychol. 2013;122(3):807&#x2013;815. doi: 10.1037/a0033759.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/a0033759</ArticleId><ArticleId IdType="pubmed">24016018</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelleher I, Cederl&#xf6;f M, Lichtenstein P. Psychotic experiences as a predictor of the natural course of suicidal ideation: A Swedish cohort study. World Psychiatry. 2014;13(2):184&#x2013;188. doi: 10.1002/wps.20131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wps.20131</ArticleId><ArticleId IdType="pmc">PMC4102291</ArticleId><ArticleId IdType="pubmed">24890071</ArticleId></ArticleIdList></Reference><Reference><Citation>Devenney EM, et al. The neural correlates and clinical characteristics of psychosis in the frontotemporal dementia continuum and the C9orf72 expansion. NeuroImage Clin. 2017;13:439&#x2013;445. doi: 10.1016/j.nicl.2016.11.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2016.11.028</ArticleId><ArticleId IdType="pmc">PMC5233794</ArticleId><ArticleId IdType="pubmed">28116236</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, et al. The ALSFRS-R: A revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci. 1999;169(1&#x2013;2):13&#x2013;21. doi: 10.1016/S0022-510X(99)00210-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(99)00210-5</ArticleId><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrahams S, et al. Relation between cognitive dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 1997;62(5):464&#x2013;472. doi: 10.1136/jnnp.62.5.464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.62.5.464</ArticleId><ArticleId IdType="pmc">PMC486852</ArticleId><ArticleId IdType="pubmed">9153602</ArticleId></ArticleIdList></Reference><Reference><Citation>Rascovsky K et al. (2011) Behavioural variant of frontotemporal dementia. 10.1093/brain/awr179</Citation></Reference><Reference><Citation>Strong MJ, et al. Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria. Amyotroph Lateral Scler Front Degener. 2017;18(3&#x2013;4):153&#x2013;174. doi: 10.1080/21678421.2016.1267768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1267768</ArticleId><ArticleId IdType="pmc">PMC7409990</ArticleId><ArticleId IdType="pubmed">28054827</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho M, et al. Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol. 2008;119(3):497&#x2013;503. doi: 10.1016/j.clinph.2007.09.143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2007.09.143</ArticleId><ArticleId IdType="pubmed">18164242</ArticleId></ArticleIdList></Reference><Reference><Citation>Shefner JM, et al. A proposal for new diagnostic criteria for ALS. Clin Neurophysiol. 2020;131(8):1975&#x2013;1978. doi: 10.1016/j.clinph.2020.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2020.04.005</ArticleId><ArticleId IdType="pubmed">32387049</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh S, Schubert S, Hoon C, Mioshi E, Hodges JR. Validation of the Addenbrooke&#x2019;s cognitive examination III in frontotemporal dementia and Alzheimer&#x2019;s disease. Dement Geriatr Cogn Disord. 2013;36(3&#x2013;4):242&#x2013;250. doi: 10.1159/000351671.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000351671</ArticleId><ArticleId IdType="pubmed">23949210</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS&#x2013;FTD. Neuron. 2011;72(2):257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>American Psychiatric Association (2013) Highlights of changes from DSM-IV to DSM-5,&#x201d; Diagnostic Stat Man Ment Disord 11(4), 525&#x2013;527 10.1176/appi.books.9780890425596.changes</Citation></Reference><Reference><Citation>Fonseca-Pedrero E, et al. The structure of schizotypal personality traits: A cross-national study. Psychol Med. 2018;48(3):451&#x2013;462. doi: 10.1017/S0033291717001829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291717001829</ArticleId><ArticleId IdType="pubmed">28712364</ArticleId></ArticleIdList></Reference><Reference><Citation>Raine A. The spq: A scale for the assessment of schizotypal personality based on DSM-III-r criteria. Schizophr Bull. 1991;17(4):555&#x2013;564. doi: 10.1093/schbul/17.4.555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/schbul/17.4.555</ArticleId><ArticleId IdType="pubmed">1805349</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed RM, et al. Tackling clinical heterogeneity across the amyotrophic lateral sclerosis&#x2013;frontotemporal dementia spectrum using a transdiagnostic approach. Brain Commun. 2021;3(4):1&#x2013;14. doi: 10.1093/braincomms/fcab257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcab257</ArticleId><ArticleId IdType="pmc">PMC8599039</ArticleId><ArticleId IdType="pubmed">34805999</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Yu JT, Sun FR, Ou JR, Ben Qu S, Tan L. &#x201c;The clinical and pathological phenotypes of frontotemporal dementia with C9ORF72 mutations. J Neurol Sci. 2013;335(1&#x2013;2):26&#x2013;35. doi: 10.1016/j.jns.2013.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2013.09.013</ArticleId><ArticleId IdType="pubmed">24090760</ArticleId></ArticleIdList></Reference><Reference><Citation>Woollacott IOC, Mead S. The C9ORF72 expansion mutation: Gene structure, phenotypic and diagnostic issues. Acta Neuropathol. 2014;127(3):319&#x2013;332. doi: 10.1007/s00401-014-1253-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1253-7</ArticleId><ArticleId IdType="pubmed">24515836</ArticleId></ArticleIdList></Reference><Reference><Citation>De Souza PVS, Pinto WBVDR, Oliveira ASB. Dist&#xfa;rbios relacionados ao C9orf72: Expandindo o espectro cl&#xed;nico e gen&#xe9;tico das doen&#xe7;as neurodegenerativas. Arq Neuropsiquiatr. 2015;73(3):246&#x2013;256. doi: 10.1590/0004-282X20140229.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0004-282X20140229</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultze-Lutter F, Nenadic I, Grant P. Psychosis and schizophrenia-spectrum personality disorders require early detection on different symptom dimensions. Front. Psychiatry. 2019 doi: 10.3389/fpsyt.2019.00476.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2019.00476</ArticleId><ArticleId IdType="pmc">PMC6637034</ArticleId><ArticleId IdType="pubmed">31354543</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollema MG, Sitskoorn MM, Appels MCM, Kahn RS. Does the Schizotypal Personality Questionnaire reflect the biological-genetic vulnerability to schizophrenia? Schizophr Res. 2002;54(1&#x2013;2):39&#x2013;45. doi: 10.1016/S0920-9964(01)00350-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0920-9964(01)00350-4</ArticleId><ArticleId IdType="pubmed">11853977</ArticleId></ArticleIdList></Reference><Reference><Citation>Torgersen S, et al. Schizotypal personality disorder inside and outside the schizophrenic spectrum. Schizophr Res. 2002;54(1&#x2013;2):33&#x2013;38. doi: 10.1016/S0920-9964(01)00349-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0920-9964(01)00349-8</ArticleId><ArticleId IdType="pubmed">11853976</ArticleId></ArticleIdList></Reference><Reference><Citation>Dietsche B, Kircher T, Falkenberg I. Structural brain changes in schizophrenia at different stages of the illness: A selective review of longitudinal magnetic resonance imaging studies. Aust N Z J Psychiatry. 2017;51(5):500&#x2013;508. doi: 10.1177/0004867417699473.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0004867417699473</ArticleId><ArticleId IdType="pubmed">28415873</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu ML, et al. A review of the functional and anatomical default mode network in schizophrenia. Neurosci Bull. 2017;33(1):73&#x2013;84. doi: 10.1007/s12264-016-0090-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12264-016-0090-1</ArticleId><ArticleId IdType="pmc">PMC5567552</ArticleId><ArticleId IdType="pubmed">27995564</ArticleId></ArticleIdList></Reference><Reference><Citation>Birur B, Kraguljac NV, Shelton RC, Lahti AC. Brain structure, function, and neurochemistry in schizophrenia and bipolar disorder- A systematic review of the magnetic resonance neuroimaging literature. Npj Schizophr. 2017;3(1):1&#x2013;14. doi: 10.1038/s41537-017-0013-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41537-017-0013-9</ArticleId><ArticleId IdType="pmc">PMC5441538</ArticleId><ArticleId IdType="pubmed">28560261</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirschner M, et al. Ventral striatal dysfunction and symptom expression in individuals with schizotypal personality traits and early psychosis. Schizophr Bull. 2018;44(1):147&#x2013;157. doi: 10.1093/schbul/sbw142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/schbul/sbw142</ArticleId><ArticleId IdType="pmc">PMC5767950</ArticleId><ArticleId IdType="pubmed">27798223</ArticleId></ArticleIdList></Reference><Reference><Citation>Fornito A, et al. Functional dysconnectivity of corticostriatal circuitry as a risk phenotype for psychosis. JAMA Psychiat. 2013;70(11):1143&#x2013;1151. doi: 10.1001/jamapsychiatry.2013.1976.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2013.1976</ArticleId><ArticleId IdType="pubmed">24005188</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo C, Hu N, Xiao Y, Zhang W, Gong Q, Lui S. Comparison of gray matter atrophy in behavioral variant frontal temporal dementia and amyotrophic lateral sclerosis: a coordinate-based meta-analysis. Front Aging Neurosci. 2020;12(February):1&#x2013;12. doi: 10.3389/fnagi.2020.00014.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2020.00014</ArticleId><ArticleId IdType="pmc">PMC7026505</ArticleId><ArticleId IdType="pubmed">32116647</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan PL, et al. Gray matter atrophy in behavioral variant frontotemporal dementia: A meta-analysis of voxel-based morphometry studies. Dement Geriatr Cogn Disord. 2012;33(2&#x2013;3):141&#x2013;148. doi: 10.1159/000338176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000338176</ArticleId><ArticleId IdType="pubmed">22722668</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan PL, Liu Y, Zhang Y, Zhao H, Ye X, Xu Y. Brain gray matter abnormalities in progressive supranuclear palsy revisited. Oncotarget. 2017;8(46):80941&#x2013;80955. doi: 10.18632/oncotarget.20895.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.20895</ArticleId><ArticleId IdType="pmc">PMC5655252</ArticleId><ArticleId IdType="pubmed">29113357</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes G. The cerebellum of man. Brain. 1939;62(1):1&#x2013;30. doi: 10.1093/brain/62.1.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/62.1.1</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Kumfor F, Landin-Romero R, Irish M, Hodges JR, Piguet O. Cerebellar atrophy and its contribution to cognition in frontotemporal dementias. Ann Neurol. 2018;84(1):98&#x2013;109. doi: 10.1002/ana.25271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25271</ArticleId><ArticleId IdType="pubmed">30014499</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan RH, Devenney E, Kiernan MC, Halliday GM, Hodges JR, Hornberger M. Terra incognita-cerebellar contributions to neuropsychiatric and cognitive dysfunction in behavioral variant frontotemporal dementia. Front Aging Neurosci. 2015;7:1&#x2013;9. doi: 10.3389/fnagi.2015.00121.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2015.00121</ArticleId><ArticleId IdType="pmc">PMC4488961</ArticleId><ArticleId IdType="pubmed">26191000</ArticleId></ArticleIdList></Reference><Reference><Citation>Tse NY, et al. Cerebellar contributions to cognition in corticobasal syndrome and progressive supranuclear palsy. Brain Commun. 2020;2(2):1&#x2013;13. doi: 10.1093/braincomms/fcaa194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa194</ArticleId><ArticleId IdType="pmc">PMC7753056</ArticleId><ArticleId IdType="pubmed">33381758</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoodley CJ. The cerebellum and cognition : evidence from functional imaging studies. The Cerebellum. 2012 doi: 10.1007/s12311-011-0260-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12311-011-0260-7</ArticleId><ArticleId IdType="pubmed">21373864</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Landin-Romero R, Kumfor F, Irish M, Hodges JR, Piguet O. Cerebellar structural connectivity and contributions to cognition in frontotemporal dementias. Cortex. 2020;129:57&#x2013;67. doi: 10.1016/j.cortex.2020.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cortex.2020.04.013</ArticleId><ArticleId IdType="pubmed">32428762</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmahmann JD. Dysmetria of thought: Clinical consequences of cerebellar dysfunction on cognition and affect. Trends Cogn Sci. 1998;2(9):362&#x2013;371. doi: 10.1016/S1364-6613(98)01218-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1364-6613(98)01218-2</ArticleId><ArticleId IdType="pubmed">21227233</ArticleId></ArticleIdList></Reference><Reference><Citation>Devenney EM, et al. Neural mechanisms of psychosis vulnerability and perceptual abnormalities in the ALS&#x2013;FTD spectrum. Ann Clin Transl Neurol. 2021;8(8):1576&#x2013;1591. doi: 10.1002/acn3.51363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51363</ArticleId><ArticleId IdType="pmc">PMC8351398</ArticleId><ArticleId IdType="pubmed">34156763</ArticleId></ArticleIdList></Reference><Reference><Citation>Felgoise SH, et al. Psychological morbidity in ALS: The importance of psychological assessment beyond depression alone. Amyotroph Lateral Scler. 2010;11(4):351&#x2013;358. doi: 10.3109/17482961003667630.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482961003667630</ArticleId><ArticleId IdType="pubmed">20235756</ArticleId></ArticleIdList></Reference><Reference><Citation>Fornito A, Bullmore ET, Zalesky A. Opportunities and Challenges for Psychiatry in the Connectomic Era. Biol Psychiatry Cogn Neurosci Neuroimaging. 2017;2(1):9&#x2013;19. doi: 10.1016/j.bpsc.2016.08.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpsc.2016.08.003</ArticleId><ArticleId IdType="pubmed">29560890</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan MC, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377(9769):942&#x2013;955. doi: 10.1016/S0140-6736(10)61156-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, et al. Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol. 2013;12(3):310&#x2013;322. doi: 10.1016/S1474-4422(13)70036-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(13)70036-X</ArticleId><ArticleId IdType="pmc">PMC4565161</ArticleId><ArticleId IdType="pubmed">23415570</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan MC, et al. Improving clinical trial outcomes in amyotrophic lateral sclerosis. Nat Rev Neurol. 2021;17(2):104&#x2013;118. doi: 10.1038/s41582-020-00434-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-00434-z</ArticleId><ArticleId IdType="pmc">PMC7747476</ArticleId><ArticleId IdType="pubmed">33340024</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>